Tenax Therapeutics (TENX) Gains from Investment Securities: 2013-2017
Historic Gains from Investment Securities for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $3.8 million.
- Tenax Therapeutics' Gains from Investment Securities fell 6.80% to $3.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $3.8 million, marking a year-over-year decrease of 6.80%. This contributed to the annual value of -$1,000 for FY2023, which is 134.47% down from last year.
- According to the latest figures from Q3 2017, Tenax Therapeutics' Gains from Investment Securities is $3.8 million, which was down 11.67% from $4.3 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Gains from Investment Securities registered a high of $4.7 million during Q1 2017, and its lowest value of -$2,519 during Q2 2014.
- Moreover, its 3-year median value for Gains from Investment Securities was $3.8 million (2015), whereas its average is $3.1 million.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 7,189.96% in 2014, then dropped by 6.80% in 2017.
- Quarterly analysis of 5 years shows Tenax Therapeutics' Gains from Investment Securities stood at $50,678 in 2013, then skyrocketed by 7,189.96% to $3.7 million in 2014, then rose by 1.58% to $3.8 million in 2015, then reached $74,388 in 2016, then dropped by 6.80% to $3.8 million in 2017.
- Its Gains from Investment Securities was $3.8 million in Q3 2017, compared to $4.3 million in Q2 2017 and $4.7 million in Q1 2017.